🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused measures to address cost of living pressures" in the forthcoming financial statement.

In comments to the BBC, she noted that reducing price rises is a joint task of both the administration and the Bank of England.

The UK's price growth is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Interventions

It is understood the government could take action to lower utility costs, for instance by reducing the current 5% rate of VAT applied on energy supplies.

An additional option is to lower some of the regulatory levies presently added to bills.

Budgetary Limitations and Analyst Predictions

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much space there is for such measures.

The expectation from the majority of economists is that the Chancellor will have to declare tax rises or budget cuts in order to meet her self-imposed fiscal targets.

Earlier on the same day, calculations showed there was a £22 billion deficit for the chancellor to address, which is at the lower end of forecasts.

"There's a joint task between the central bank and the government to continue tackling some of the causes of inflation," Reeves informed the BBC in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on expected tax rises, the Treasury chief said the latest figures from the OBR had not altered her pledge to manifesto promises not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with rising international and commercial issues for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."

Global Trade Disputes

Addressing concerns about the United Kingdom's trade ties with the Asian nation she said: "Our security interests invariably come first."

Last week's declaration by China to tighten trade restrictions on rare earths and other materials that are key for high-technology production led US President the US President to propose an additional 100% tariff on imports from China, increasing the risk of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese move "economic coercion" and "a international production power grab."

Inquired about considering the American proposal to join its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the world economy and causes additional headwinds."

"It is my opinion there are areas where we must confront Chinese policies, but there are also valuable prospects to export to Chinese markets, including banking sector and other areas of the economy. We've got to achieve that equilibrium correct."

The Treasury chief also confirmed she was working with other major economies "regarding our own critical minerals plan, so that we are less reliant."

Health Service Drug Pricing and Funding

Reeves also admitted that the cost the National Health Service pays for medicines could increase as a result of current discussions with the US government and its drugs companies, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said lately that they are either delaying or scrapping operations in the United Kingdom, with several attributing the low prices they are obtaining.

Recently, the government science advisor said the cost the NHS spends on drugs would have to go up to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor stated to media: "It has been observed as a result of the cost structure, that medical research, innovative medicines have not been provided in the United Kingdom in the manner that they are in other European countries."

"Our aim is to guarantee that people getting care from the NHS are can receive the top life-saving drugs in the globe. And so we are looking at all of that, and... looking to secure increased capital into Britain."